Melanie Juilland
Overview
Explore the profile of Melanie Juilland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vallois D, Juilland M, Ioannidou K, Lemonnier F, Missiaglia E, Bisig B, et al.
Blood Adv
. 2025 Feb;
PMID: 40020168
The RHOA G17V mutation is highly recurrent in follicular helper T-cell (TFH) lymphoma of the angioimmunoblastic type (AITL) (60-70% of cases) and frequently associated with mutations in other T-cell receptor...
2.
Juilland M, Alouche N, Ubezzi I, Gonzalez M, Rashid H, Scarpellino L, et al.
Proc Natl Acad Sci U S A
. 2023 Dec;
120(52):e2301155120.
PMID: 38109544
The protease MALT1 promotes lymphocyte activation and lymphomagenesis by cleaving a limited set of cellular substrates, most of which control gene expression. Here, we identified the integrin-binding scaffold protein Tensin-3...
3.
Luong-Gardiol N, Siddiqui I, Pizzitola I, Jeevan-Raj B, Charmoy M, Huang Y, et al.
Cancer Cell
. 2019 Apr;
35(4):649-663.e10.
PMID: 30991025
The BCR-ABL1 fusion protein is the cause of chronic myeloid leukemia (CML) and of a significant fraction of adult-onset B cell acute lymphoblastic leukemia (B-ALL) cases. Using mouse models and...
4.
Juilland M, Thome M
Front Immunol
. 2018 Sep;
9:1927.
PMID: 30214442
The scaffold proteins CARMA1-3 (encoded by the genes and -) and CARD9 play major roles in signaling downstream of receptors with immunoreceptor tyrosine activation motifs (ITAMs), G-protein coupled receptors (GPCR)...
5.
Juilland M, Bonsignore L, Thome M
Oncotarget
. 2018 Mar;
9(16):12542-12543.
PMID: 29560084
No abstract available.
6.
Dai B, Grau M, Juilland M, Klener P, Horing E, Molinsky J, et al.
Blood
. 2016 Nov;
129(3):333-346.
PMID: 27864294
Mantle cell lymphoma (MCL) is a mature B-cell lymphoma characterized by poor clinical outcome. Recent studies revealed the importance of B-cell receptor (BCR) signaling in maintaining MCL survival. However, it...
7.
Vallois D, Dobay M, Morin R, Lemonnier F, Missiaglia E, Juilland M, et al.
Blood
. 2016 Jul;
128(11):1490-502.
PMID: 27369867
Angioimmunoblastic T-cell lymphoma (AITL) and other lymphomas derived from follicular T-helper cells (TFH) represent a large proportion of peripheral T-cell lymphomas (PTCLs) with poorly understood pathogenesis and unfavorable treatment results....
8.
Juilland M, Thome M
Curr Opin Hematol
. 2016 May;
23(4):402-9.
PMID: 27135977
Purpose Of Review: The CARMA1/BCL10/MALT1 (CBM) complex is a multimeric signaling complex controlling several important aspects of lymphocyte activation. Gain-of-function mutations in the genes encoding CBM proteins or their upstream...
9.
Juilland M, Gonzalez M, Erdmann T, Banz Y, Jevnikar Z, Hailfinger S, et al.
Blood
. 2016 Jan;
127(14):1780-9.
PMID: 26747248
A hallmark of the diffuse large B-cell lymphoma (DLBCL) of the activated B-cell (ABC) type, a molecular subtype characterized by adverse outcome, is constitutive activation of the transcription factor nuclear...